Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Kehinde Ross, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Targeting immunosenescence for improved tumor immunotherapy
Zaoqu Liu, Lulu Zuo, Zhaokai Zhou, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
CRISPR, CAR-T, and NK: Current applications and future perspectives
Mohadeseh Khoshandam, Hossein Soltaninejad, Amir Ali Hamidieh, et al.
Genes & Diseases (2023) Vol. 11, Iss. 4, pp. 101121-101121
Open Access | Times Cited: 6
Recent Progress in Prompt Molecular Detection of Exosomes Using CRISPR/Cas and Microfluidic‐Assisted Approaches Toward Smart Cancer Diagnosis and Analysis
Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Masoomeh Yari Kalashgrani, et al.
ChemMedChem (2023) Vol. 19, Iss. 1
Closed Access | Times Cited: 6
Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9
Muniba Mahmood, Izza Taufiq, Sidra Mazhar, et al.
Personalized Medicine (2024) Vol. 21, Iss. 3, pp. 175-190
Closed Access | Times Cited: 1
Molecular methods in cancer diagnostics: a short review
Tanushree Budhbaware, Jaishriram Rathored, Sandesh Shende
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 1
Towards Personalized Cancer Care: A Report of CRISPR-Cas9 Applications in Targeted Therapies and Precision Medicine
Ayesha Noor, Bilal Asif, Umer Ali
Journal of Health and Rehabilitation Research (2024) Vol. 4, Iss. 2, pp. 1375-1380
Open Access | Times Cited: 1
Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment
Ling-Wu Tong, Yongshan Hu, Shi-Jing Yu, et al.
Nanotechnology (2024) Vol. 35, Iss. 40, pp. 402002-402002
Closed Access | Times Cited: 1
Role of next‐generation sequencing in revolutionizing healthcare for cancer management
Om Saswat Sahoo, Hiya Aidasani, Arnab Nayek, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access | Times Cited: 1
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview
Pankaj Garg, G. D. Singhal, Siddhika Pareek, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189233-189233
Open Access | Times Cited: 1
Exosome-Mediated Delivery of CRISPR-Cas9: A Revolutionary Approach to Cancer Gene Editing
Ashok Kumar Balaraman, M. Arockia Babu, Ehssan Moglad, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155785-155785
Closed Access | Times Cited: 1
ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
Yong Cui, Yong-Yong Dong
Aging (2022) Vol. 14, Iss. 18, pp. 7505-7516
Open Access | Times Cited: 7
Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma
Guicao Yin, Tai Tian, Xing Ji, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Exploring Single-Cell Exposomics by Mass Spectrometry
Peng Gao
Environmental Science & Technology (2023) Vol. 57, Iss. 33, pp. 12201-12209
Open Access | Times Cited: 3
The Dawn of In Vivo Gene Editing Era: A Revolution in the Making
Sarfaraz K. Niazi
Biologics (2023) Vol. 3, Iss. 4, pp. 253-295
Open Access | Times Cited: 3
The role of genetics in determining resistance to coccidiosis in goats a review of current research and future directions
Tejswini Sontakke, Ashwini Biradar, Dinesh Nalage
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6171-6175
Closed Access | Times Cited: 2
Experimental Models for Rare Melanoma Research—The Niche That Needs to Be Addressed
Ioana Ioniță, Daniel Malița, Cristina Dehelean, et al.
Bioengineering (2023) Vol. 10, Iss. 6, pp. 673-673
Open Access | Times Cited: 2
Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer
Shreyasi Maity, Rishyani Mukherjee, Satarupa Banerjee
Molecular Biotechnology (2022) Vol. 65, Iss. 2, pp. 206-226
Closed Access | Times Cited: 4
Mitigating the Off-target Effects in CRISPR/Cas9-mediated Genetic Editing with Bioinformatic Technologies
Shixing Yuan
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 3, pp. 318-326
Open Access
Technology for Studying Multi-omics
Truong Pham Thanh, Yen-Vy Nguyen Thi, Dinh‐Toi Chu
(2024), pp. 31-47
Closed Access
Application of CRISPR–Cas Technology in Drug Development
Sidra Altaf, Faiza Saleem, H Ikram, et al.
(2024), pp. 203-245
Closed Access
Expression Analysis of Circulating microRNAs in Saliva and Plasma for the Identification of Clinically Relevant Biomarkers for Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders
Federica Rocchetti, Gianluca Tenore, Federica Macali, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2990-2990
Open Access
Nanomedicine Therapies for Pediatric Diseases
Shicheng Yang, Kushi Aggarwal, Jillian Jurczyszak, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Open Access
Integrating computational biology and multiomics data for precision medicine in personalized cancer treatment
Chandan Shivamallu, Chattu Bhargavi, S Bhavana, et al.
Elsevier eBooks (2024), pp. 249-277
Closed Access
Advances and prospects of precision nanomedicine in personalized tumor theranostics
Yuhang Mao, Juanping Xie, Fang Yang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access

Scroll to top